# US 2010/0135962 A1 · Novel Bacteriophage and Antibacterial Composition Comprising the Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0135962 A1
- Document ID: US20100135962A1
- Status: Published application
- Kind: A1
- Application number: 12/550,304
- Filed: 2009-08-28
- Published: 2010-06-03
- Earliest claimed: 2008-12-02
- Assignees: Cj Cheiljedang Corporation
- Inventors: In Hye KANG; Min Tae Park; Young Wook Cho; Hyang Choi; Soo An Shin
- Web page: https://patentgrep.com/patent/US20100135962A1

## CPC

- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- A61P 31/04: Antibacterial agents
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 37/04: Immunostimulants
- C07K 14/005: from viruses
- A61K 2035/11: {Medicinal preparations comprising living procariotic cells}
- C12N 2795/10321: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2795/10322: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to a novel bacteriophage, more particularly, a bacteriophage that has a specific bactericidal activity against Fowl Typhoid causing Salmonella Gallinarum (SG) and Pullorum disease-causing Salmonella Pullorum (SP). Further, the present invention relates to a composition for the prevention or treatment of infectious diseases caused by Salmonella Gallinarum or Salmonella Pullorum, comprising the bacteriophage as an active ingredient. Furthermore, the present invention relates to feed and drinking water for poultry, sanitizers and cleaners, comprising the bacteriophage as an active ingredient.

## Claims

### Claim 1

An isolated bacteriophage having a specific bactericidal activity against Salmonella Gallinarum and Salmonella Pullorum, the bacteriophage belonging to the morphotype group B1 of the family Siphoviridae, and comprising a total genome of approximately 61 kbp and major structural proteins of 38 kDa and 49 kDa.

### Claim 2 (depends on 1)

The bacteriophage according to claim 1, wherein the bacteriophage comprises an isometric capsid and a long non-contractile tail.

### Claim 3 (depends on 1)

The bacteriophage according to claim 1, wherein the bacteriophage comprises one or more nucleic acid sequences selected from the group consisting of SEQ ID NOs. 1, 2, 3, 4, and 5.

### Claim 4 (depends on 1)

The bacteriophage according to claim 1, wherein PCR amplification of the bacteriophage DNA provides PCR products of approximately 660 bp, 670 bp, 1.3 kbp, 1.8 kbp, 1 kbp, 1 kbp, and 1 kbp when using a primer set of SEQ ID NOs. 6 and 7, SEQ ID NOs. 8 and 9, SEQ ID NOs. 10 and 11, SEQ ID NOs. 12 and 13, SEQ ID NOs. 14 and 15, SEQ ID NOs. 16 and 17, and SEQ ID NOs. 18 and 19, respectively.

### Claim 5 (depends on 1)

The bacteriophage according to claim 1, wherein the bacteriophage is characterized by acid-resistance in a pH range from pH 2.5 to pH 9.0, heat-resistance in a temperature range from 37° C. to 70° C., and dry-resistance at 60° C. for 120 minutes.

### Claim 6 (depends on 1)

The bacteriophage according to claim 1, wherein the bacteriophage is the bacteriophage deposited under accession number KCCM10969P.

### Claim 7 (depends on 1)

A composition for the prevention or treatment of infectious diseases caused by Salmonella Gallinarum or Salmonella Pullorum, comprising the bacteriophage of claim 1 as an active ingredient.

### Claim 8 (depends on 7)

The composition according to claim 7, wherein the infectious disease is selected from Fowl Typhoid and Pullorum disease.

### Claim 9 (depends on 7)

The composition according to claim 7, wherein the composition is used as an antibiotic.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6)

An animal feed or drinking water, comprising the bacteriophage of any one of claims 1 to 6 as an active ingredient.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6)

A sanitizer or cleaner, comprising the bacteriophage of any one of claims 1 to 6 as an active ingredient.

### Claim 12 (depends on 1)

A method for treating an infectious disease caused by Salmonella Gallinarum or Salmonella Pullorum, comprising administering the bacteriophage of claim 1 to an animal in need thereof.

### Claim 13 (depends on 7)

A method for treating an infectious disease caused by Salmonella Gallinarum or Salmonella Pullorum, comprising administering the composition of claim 7 to an animal in need thereof.
